Faculty

Institution

Unit

Venue

Elizabeth Grimm

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Experimental Therapeutics

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

NoneElizabeth Grimm is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elizabeth Grimm

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

immunology cell biology melanoma cancer research tumor biology cancer cells oncology immune responses cancer immunotherapy cellular therapy immunotherapy dermatology cancer biology oncogenes skin cancer molecular cancer cell death cell research pathology medicinal research inflammation cellular immune responses experimental medicine cytokines immunologic mechanisms cancer treatment immunomodulation cancer genetics tumor microenvironment leukemia cancer genomics photocarcinogenesis cancer care cancer immunosurveillance cancer discovery brain tumor research tumor suppressors immune checkpoint inhibitors vascular biology cell transplantation immunosuppression tumor targeting cancer imaging apoptosis anti-cancer agents cutaneous melanoma innate immune system cancer growth human melanoma cancer risk clinical immunology cell regulation adaptive immune system nitric oxide human melanoma cells surgical oncology immune mediators novel therapies molecular immunology immunopathology interleukin 2 lymphoid neoplasia receptor tyrosine kinases lymphokine-activated killer cells uveal melanoma malignant glioma melanoma patients melanoma cells pancreatic cancer host response poor survival tumor necrosis factor adoptive immunotherapy single cell level human tumors killer cells

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterizing Spatial Immune Architecture in Metastatic Melanoma Using High-Dimensional Multiplex Imaging. Frontiers in Immunology (2025)

immune responsesmelanomacancer imagingimmunology

Development of a Human Colorectal Carcinoma Cell-Based Platform for Studying Inducible Nitric Oxide Synthase Expression and Nitric Oxide Signaling Dynamics. Frontiers in Molecular Biosciences (2025)

cancer biologynitrosative stressmolecular cancercancer cellscancer researchcolorectal cancerreactive nitrogen speciesoxidative stresssynthase expressionsystems biologytumor biologynitric oxidecarcinogenesiscell biology

S-Nitrosylation of P53 in Melanoma Cells Under Nitrosative Stress. International Journal of Molecular Sciences (2025)

molecular cancertumor suppressorscancer cellsoncogenescancer researchmelanomamelanoma cellstumor biologyphotocarcinogenesiscarcinogenesiscell biology

Imipridones Inhibit Tumor Growth and Improve Survival in an Orthotopic Liver Metastasis Mouse Model of Human Uveal Melanoma. British Journal of Cancer (2024)

pharmacologycancer biologytumor growthhuman uveal melanomacancer cellsoncogenescancer researchmelanomametastasisanti-cancer agentstumor biologycell biologytherapeutic targets

Abstract 4785: S-Nitrosylation of P53 in Melanoma Alters P53-Dna Binding and Downstream Gene Expression. Cancer Research (2023)

Jordan WinfieldMariana GrigorutaYiliang LiFancui MengYong QinElizabeth GrimmLeyuan ChenKevin RosenblattLi Li

geneticscancer biologymolecular cancercancer imaginggene expressioncancer treatmentgene therapyoncogenescancer researchoncologymelanomacancer genomicsradiation oncologyleukemiamolecular biologycancer geneticstumor biologydownstream gene expression

Data From Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. (2023)

Yong QinJason RoszikChandrani ChattopadhyayYuuri HashimotoChengwen LiuZachary A. CooperJennifer A. WargoPatrick HwuSuhendan EkmekciogluElizabeth A. Grimm

pathologydrug resistancemolecular cancercancer genomicstumor biologydermatologyvascular biologypharmacologyinflammationoncologyvemurafenib resistanceskin cancerremedial actioncancer immunotherapyhypoxia (medicine)cancer imagingmelanomaleukemiahypoxia-driven mechanismmedicinal research

S-Nitrosylation of P53 Under Nitrosative Stress. SSRN Electronic Journal (2023)

Mariana GrigorutaLi LiLeyuan ChenFancui MengJordan WinfieldKevin P. RosenblattYiliang LiElizabeth A. GrimmYong Qin

geneticsneurologynitrosative stressmolecular cancerdna repaircancer researchneuro-oncologybrain tumor researchcancer genomicsmolecular biologytumor biology

Supplementary Data From the Cox2 Effector Microsomal Pge2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma. (2023)

Sun-Hee KimJason RoszikSung-Nam ChoDai OgataDenái R. MiltonWeiyi PengDavid G. MenterSuhendan EkmekciogluElizabeth A. Grimm

pharmacologycancer immunotherapymolecular cancersupplementary datacutaneous melanomacancer researchmolecular medicineoncologymelanomacancer genomicsleukemiaimmunosuppressioncell regulationtumor biologyimmunologydermatologymedicinal researchskin cancer

Supplementary Figures and Tables From Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. (2023)

Yong QinJason RoszikChandrani ChattopadhyayYuuri HashimotoChengwen LiuZachary A. CooperJennifer A. WargoPatrick HwuSuhendan EkmekciogluElizabeth A. Grimm

hypoxia (medicine)drug resistancemelanomahypoxia-driven mechanismvemurafenib resistanceimmunology

Supplementary Table S2 From Inflammatory Marker Testing Identifies Cd74 Expression in Melanoma Tumor Cells, and Its Expression Associates With Favorable Survival for Stage III Melanoma. (2023)

Suhendan EkmekciogluMichael A. DaviesKeiji TaneseJason RoszikMyung Shin-SimRoland L. BassettDenái R. MiltonScott E. WoodmanVictor G. PrietoJeffrey E. GershenwaldDonald L. MortonDave S. HoonElizabeth A. Grimm

inflammationmelanomastage iii melanomamolecular biologymelanoma tumor cellsfavorable survivalinflammatory markers

1
2
3
4
5
31
10 / page

Elizabeth Grimm

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Experimental Therapeutics

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

NoneElizabeth Grimm is currently serving as a Breast Surgical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elizabeth Grimm

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characterizing Spatial Immune Architecture in Metastatic Melanoma Using High-Dimensional Multiplex Imaging. Frontiers in Immunology (2025)

immune responsesmelanomacancer imagingimmunology

S-Nitrosylation of P53 in Melanoma Cells Under Nitrosative Stress. International Journal of Molecular Sciences (2025)

molecular cancertumor suppressorscancer cellsoncogenescancer researchmelanomamelanoma cellstumor biologyphotocarcinogenesiscarcinogenesiscell biology

Imipridones Inhibit Tumor Growth and Improve Survival in an Orthotopic Liver Metastasis Mouse Model of Human Uveal Melanoma. British Journal of Cancer (2024)

pharmacologycancer biologytumor growthhuman uveal melanomacancer cellsoncogenescancer researchmelanomametastasisanti-cancer agentstumor biologycell biologytherapeutic targets

Abstract 4785: S-Nitrosylation of P53 in Melanoma Alters P53-Dna Binding and Downstream Gene Expression. Cancer Research (2023)

Jordan WinfieldMariana GrigorutaYiliang LiFancui MengYong QinElizabeth GrimmLeyuan ChenKevin RosenblattLi Li

Data From Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. (2023)

Yong QinJason RoszikChandrani ChattopadhyayYuuri HashimotoChengwen LiuZachary A. CooperJennifer A. WargoPatrick HwuSuhendan EkmekciogluElizabeth A. Grimm

S-Nitrosylation of P53 Under Nitrosative Stress. SSRN Electronic Journal (2023)

Mariana GrigorutaLi LiLeyuan ChenFancui MengJordan WinfieldKevin P. RosenblattYiliang LiElizabeth A. GrimmYong Qin

geneticsneurologynitrosative stressmolecular cancerdna repaircancer researchneuro-oncologybrain tumor researchcancer genomicsmolecular biologytumor biology

Supplementary Data From the Cox2 Effector Microsomal Pge2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma. (2023)

Sun-Hee KimJason RoszikSung-Nam ChoDai OgataDenái R. MiltonWeiyi PengDavid G. MenterSuhendan EkmekciogluElizabeth A. Grimm

Supplementary Figures and Tables From Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. (2023)

Yong QinJason RoszikChandrani ChattopadhyayYuuri HashimotoChengwen LiuZachary A. CooperJennifer A. WargoPatrick HwuSuhendan EkmekciogluElizabeth A. Grimm

hypoxia (medicine)drug resistancemelanomahypoxia-driven mechanismvemurafenib resistanceimmunology

Supplementary Table S2 From Inflammatory Marker Testing Identifies Cd74 Expression in Melanoma Tumor Cells, and Its Expression Associates With Favorable Survival for Stage III Melanoma. (2023)

inflammationmelanomastage iii melanomamolecular biologymelanoma tumor cellsfavorable survivalinflammatory markers

1
2
3
4
5
31
10 / page